The germinal center B-cell-like (GCB) subtype was defined as the identification of CD10+ or CD10–/BCL6+/MUM-1– tumor cells (Hans et al. 2004; Oschlies et al. 2006). This evidence concerns the gene BCL6 and neoplasm.